Fidelity Investments’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Fidelity Investments’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-9,057	Closed	-$181K	–	5695
2022 Q3	$181K	Sell	9,057 -30,414	-77%	-$401K	﹤0.01%	3079
2022 Q2	$272K	Sell	39,471 -1,484,592	-97%	-$10.4M	﹤0.01%	3038
2022 Q1	$14.2M	Sell	1,524,063 -2,352,990	-61%	-$25M	﹤0.01%	1962
2021 Q4	$55.1M	Sell	3,877,053 -1,196,247	-24%	-$20.7M	﹤0.01%	1385
2021 Q3	$118M	Sell	5,073,300 -754,564	-13%	-$17.8M	0.01%	1028
2021 Q2	$145M	Buy	5,827,864 +857,895	+17%	+$23.1M	0.01%	950
2021 Q1	$139M	Buy	4,969,969 +854,320	+21%	+$30.8M	0.01%	940
2020 Q4	$144M	Buy	4,115,649 +2,302,821	+127%	+$100M	0.01%	876
2020 Q3	$90.4M	Buy	1,812,828 +29,541	+2%	+$1.19M	0.01%	954
2020 Q2	$82.9M	Buy	+1,783,287	New	+$77.3M	0.01%	949

Fidelity Investments's FMTX Position: Q4 2022 in Review

Fidelity Investments sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 9,057 shares — an estimated $181K sold.

Fidelity Investments first reported a position in FMTX in Q2 2020 and held it in 10 quarters. The position peaked at $145M in Q2 2021. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

Fidelity Investments reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Fidelity Investments sold 9,057 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $181K.
Fidelity Investments first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q2 2020 and held it in 10 quarters.
Fidelity Investments's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $145M in Q2 2021.
0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Fidelity Investments's 13F filing for Q4 2022, filed 13 Feb 2023.